BIOLAB FARMA
PRODUCT
DOISKA 180MCG CAP X 30
BRIEF DESCRIPTION/INDICATION
DOISKA 180 is indicated for the prevention and treatment of age-related loss of bone mass and bone mineral density, as well as the improvement of arterial elasticity and the inhibition of vascular calcification (vascular stiffening caused by ageing and/or aggravated by various other diseases such as atherosclerosis, hypertension, diabetes and chronic kidney disease.
PRESENTATION
Soft capsule
THERAPEUTIC CLASS
DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
CLASSIFICATION
Exempt from prescription
COMPOSITE
menaeptenone
See leaflet
IF SYMPTOMS PERSIST, THE DOCTOR SHOULD BE CONSULTED.